Ā | Overall (280) | Community-acquired (71) | Healthcare-associated (53) | Hospital-acquired (156) | P value | Post-hoc analysis |
---|---|---|---|---|---|---|
Age | 69.92āĀ±ā12.95 | 72.99āĀ±ā13.57 | 68.75āĀ±ā12.37 | 68.92āĀ±ā12.72 | 0.069 | Ā |
Sex (male) | 168 (60.0) | 48 (67.6) | 34 (64.2) | 86 (55.1) | 0.162 | Ā |
Malignancy | 118 (42.1) | 19 (26.8) | 34 (64.2) | 65 (41.7) | ā<ā0.001 | HCA>CA,HA |
Diabetes | 85 (30.4) | 24 (33.8) | 13 (24.5) | 48 (30.8) | 0.532 | Ā |
Hypertension | 120 (42.9) | 30 (42.3) | 27 (50.9) | 63 (40.4) | 0.411 | Ā |
Cardiovascular disease | 73 (26.1) | 13 (18.3) | 8 (15.1) | 52 (33.3) | 0.007 | HA>HCA |
Pulmonary disease | 26 (9.3) | 7 (9.9) | 1 (1.9) | 18 (11.5) | 0.093 | Ā |
Liver disease | 56 (20.0) | 24 (33.8) | 10 (18.9) | 22 (14.2) | 0.004 | CA>HA |
Rheumatologic disease | 12 (4.3) | 1 (1.4) | 1 (1.9) | 12 (4.3) | 0.184 | Ā |
Renal disease | 25 (8.9) | 3 (4.2) | 3 (5.7) | 19 (12.2) | 0.136 | Ā |
Solid organ transplantation | 4 (1.4) | 0 (0.0) | 0 (0.0) | 4 (2.6) | 0.392 | Ā |
Prior major surgery | 35 (12.5) | 0 (0.0) | 4 (7.5) | 31 (19.9) | ā<ā0.001 | HA>CA |
Prior antibiotics use | 124 (44.3) | 2 (2.8) | 34 (64.2) | 88 (56.4) | ā<ā0.001 | HCA,HA>CA |